RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보

      만성 간질환 및 간경변증에 동반된 간세포암 환자에서 혈청 보체치 측정의 의의 = Significance of Serum Complement Levels in Chronic Liver Disease and Hepatocellular Carcinoma in Liver Cirrhosis만성 간질환 및 간경변증에 동반된 간세포암 환자에서 혈청 보체치 측정의 의의

      한글로보기

      https://www.riss.kr/link?id=A3306428

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Serum complement levels were evaluated retrospectively in 68 patients with chronic liver diseases: 21 patients with chronic active hepatitis, 25 patients with liver cirrhosis, and 22 patients with hepatocellular carcinoma in liver cirrhosis. There was no significant difference in serum complement levels between the chronic active hepatitis patients and the control group. Serum complement levels were significantly reduced in the liver cirrhosis group compared with the chronic active hepatitis and normal control groups, while hepatocellular carcinoma in the liver cirrhosis group showed significantly high serum complement levels compared with the liver cirrhosis only group. Serum C3 levels correlated well with the serum albumin levels and prolonged prothrombin times in chronic active hepatitis and liver cirrhosis patients but not in the hepatocellular carcinoma patient group. The cutoff values of the complements for detection of hepatocellular carcinoma in patients with liver cirrhosis were set according to a retrospective study. Based on these data, a prospective study was performed to detect hepatocellular carcinoma in 58 patients with liver cirrhosis. The positive predictive values, negative predictive values, and accuracies of the complements were as follows: 83.3%, 79.4%, and 81.0% for C3, 87%, 80.0%, and 82.8% for C4 respectively. Thus, these data suggest that measuring serum complement levels may be helpful in the follow-up evaluation of patients with chronic liver diseases, and the combination of complements tests and α-fetoprotein test could be useful in the early detection of hepatocellular carcinoma in liver cirrhosis patients.
      번역하기

      Serum complement levels were evaluated retrospectively in 68 patients with chronic liver diseases: 21 patients with chronic active hepatitis, 25 patients with liver cirrhosis, and 22 patients with hepatocellular carcinoma in liver cirrhosis. There was...

      Serum complement levels were evaluated retrospectively in 68 patients with chronic liver diseases: 21 patients with chronic active hepatitis, 25 patients with liver cirrhosis, and 22 patients with hepatocellular carcinoma in liver cirrhosis. There was no significant difference in serum complement levels between the chronic active hepatitis patients and the control group. Serum complement levels were significantly reduced in the liver cirrhosis group compared with the chronic active hepatitis and normal control groups, while hepatocellular carcinoma in the liver cirrhosis group showed significantly high serum complement levels compared with the liver cirrhosis only group. Serum C3 levels correlated well with the serum albumin levels and prolonged prothrombin times in chronic active hepatitis and liver cirrhosis patients but not in the hepatocellular carcinoma patient group. The cutoff values of the complements for detection of hepatocellular carcinoma in patients with liver cirrhosis were set according to a retrospective study. Based on these data, a prospective study was performed to detect hepatocellular carcinoma in 58 patients with liver cirrhosis. The positive predictive values, negative predictive values, and accuracies of the complements were as follows: 83.3%, 79.4%, and 81.0% for C3, 87%, 80.0%, and 82.8% for C4 respectively. Thus, these data suggest that measuring serum complement levels may be helpful in the follow-up evaluation of patients with chronic liver diseases, and the combination of complements tests and α-fetoprotein test could be useful in the early detection of hepatocellular carcinoma in liver cirrhosis patients.

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼